Arovella Therapeutics Limited (ASX:ALA) Suspends Quotation Pending Capital Raise
Suspension Details
Arovella Therapeutics Limited (ASX: ALA) has voluntarily suspended its securities from quotation on the Australian Securities Exchange. The suspension is effective immediately from 10 February 2025.
Capital Raising Announcement
The suspension is in anticipation of a material update regarding a capital raising placement announced on 10 January 2025. The company expects to release the announcement before normal trading resumes on 17 February 2025.
Motley Fool contributor Lauren Surplice has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.